Skip to main content

4 Result(s)

within Shohei Tsuji Remove this filter

and

  1. No Access

    Article

    Canagliflozin Inhibits Glioblastoma Growth and Proliferation by Activating AMPK

    Sodium-glucose transporter 2 (SGLT2) inhibitors are antidiabetic drugs affecting SGLT2. Recent studies have shown various cancers expressing SGLT2, and SGLT2 inhibitors attenuating tumor proliferation. We eval...

    Kenji Shoda, Shohei Tsuji, Shinsuke Nakamura… in Cellular and Molecular Neurobiology (2023)

  2. No Access

    Article

    NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells

    The alkylating agent temozolomide (TMZ) has a significant impact on the prognosis of glioblastoma (GBM) patients. Therefore, maximizing TMZ efficacy is important for GBM treatment. Many reports have shown that...

    Shohei Tsuji, Shinsuke Nakamura, Kenji Shoda, Tetsuya Yamada… in Journal of Neuro-Oncology (2022)

  3. No Access

    Article

    Deferasirox, a trivalent iron chelator, ameliorates neuronal damage in hemorrhagic stroke models

    Intracranial hemorrhage (ICH) is a devastating disease with high mortality and morbidity. After ICH, iron released from the hematoma plays a crucial role in secondary brain injury. Deferasirox (DFR) is a triva...

    Takahiko Imai, Shohei Tsuji… in Naunyn-Schmiedeberg's Archives of Pharmaco… (2021)

  4. No Access

    Article

    NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir

    This study sought to clarify the factors involved in virologic failure in patients with HCV receiving retreatment with glecaprevir/pibrentasvir (GLE/PIB) in real-world practice.

    Hayato Uemura, Yoshihito Uchida, Jun-ichi Kouyama… in Journal of Gastroenterology (2019)